Francisco Silva - Aug 26, 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
VP of Research and Development, Director
Signature
/s/ Francisco Silva
Stock symbol
BRTX
Transactions as of
Aug 26, 2022
Transactions value $
$5,367
Form type
4
Date filed
9/9/2022, 06:17 PM
Previous filing
Jun 15, 2022
Next filing
Oct 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Sale -$13.4K -3.96K -2.44% $3.39 158K Aug 26, 2022 Direct F1, F2
transaction BRTX Common Stock Purchase $8.71K +2.6K +1.64% $3.35 161K Aug 26, 2022 Direct F2
transaction BRTX Common Stock Purchase $9.05K +2.82K +1.75% $3.21 164K Aug 29, 2022 Direct F2, F3
transaction BRTX Common Stock Purchase $1.02K +307 +2.6% $3.32 12.1K Aug 29, 2022 IRA F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Stock Option 1 Aug 26, 2022 Common Stock 1 $3,000.00 Direct F5
holding BRTX Stock Option 1 Aug 26, 2022 Common Stock 1 $3,000.00 Direct F5
holding BRTX Stock Option 3 Aug 26, 2022 Common Stock 3 $3,000.00 Direct F5
holding BRTX Stock Option 1 Aug 26, 2022 Common Stock 1 $3,000.00 Direct
holding BRTX Stock Option 9 Aug 26, 2022 Common Stock 9 $3,000.00 Direct F5
holding BRTX Stock Option 6 Aug 26, 2022 Common Stock 6 $3,000.00 Direct F5
holding BRTX Stock Option 15 Aug 26, 2022 Common Stock 15 $3,000.00 Direct F5
holding BRTX Stock Option 20 Aug 26, 2022 Common Stock 20 $3,000.00 Direct F5
holding BRTX Stock Option 25 Aug 26, 2022 Common Stock 25 $3,000.00 Direct F5
holding BRTX Stock Option 293K Aug 26, 2022 Common Stock 293K $13.50 Direct F6
holding BRTX Stock Option 42.1K Aug 26, 2022 Common Stock 42.1K $13.50 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents transaction inadvertently effected by the reporting person. This transaction was executed in multiple trades at prices ranging from $3.33 to $3.45 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F2 Includes 105,081 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,036 shares on each of September 18, 2022, November 18, 2022 and January 18, 2023, 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
F3 This transaction was executed in multiple trades at prices ranging from $3.21 to $3.2159 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F4 This transaction was executed in multiple trades at prices ranging from $3.28 to $3.35 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F5 The option is currently exercisable.
F6 The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
F7 The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.